TipRanks
Go Ultimate55% OFF

RegeneRx Biopharmaceuticals (RGRX) Revenue

RegeneRx Biopharmaceuticals Revenue

RegeneRx Biopharmaceuticals had a revenue of 19.19K in the quarter ending Mar 31, 2023, with 0.00%. This bring the company's revenue in the last twelve months to 76.76K, Decreased <0.01%. In the fiscal year ending Dec 31, 2022, RegeneRx Biopharmaceuticals had annual revenue of 76.76K with 0.00% growth.

Revenue (ttm)
76.76K
Revenue Growth
―
P/S Ratio
3.37
Revenue/Employee
$38,381
Employees
2
Market Cap
$258.98K

Revenue Chart

RegeneRx Biopharmaceuticals Revenue - Annual

020K40K60K80K100K56.65K69.67K76.76K76.76K76.76K76.76K201720182019202020212022
Revenue History
Download to Excel
RGRX revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202276.76K0.000.00%
Dec 31, 202176.76K0.000.00%
Dec 31, 202076.76K-1.00>-0.01%
Dec 31, 201976.76K7.09K10.18%
Dec 31, 201869.67K13.02K22.97%
Dec 31, 201756.65K――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
RGRX76.76K
CLGN318.00K
KALA0.00
BBLG0.00
LGVN1.19M